Skip to main content
Fig. 1 | Cell & Bioscience

Fig. 1

From: The malignancy suppression and ferroptosis facilitation of BCL6 in gastric cancer mediated by FZD7 repression are strengthened by RNF180/RhoC pathway

Fig. 1

Low expression of BCL6 in GC tissues is associated with the poorer survival outcomes of GC patients. A The BCL6 mRNA expression in gastric cancer tissues and adjacent non-tumor tissues (***p < 0.001). B Immunohistochemical staining of BCL6 in gastric cancer tissues and corresponding adjacent non-tumor tissues (Original magnification, × 100 and × 400). C The BCL6 protein expression level in the most of gastric cancer tissues and corresponding adjacent non-tumor tissues (***p < 0.001). D, E The BCL6 protein expression level in different lymph node metastases (D) and tumor sizes (E) (*p < 0.05, **p < 0.001). F, G, H Keplan-Meier analysis of overall survival (F), tumor maximum diameter (TMD) (G) and lymph node node metastases subgroups (H) according to BCL6 expression level

Back to article page

Cell & Bioscience

ISSN: 2045-3701

Contact us